Skip to main content
MAZESector not reported

Maze Therapeutics, Inc. (MAZE) Insider Trading

In the last 90 days, 4 Maze Therapeutics, Inc. (MAZE) insiders reported no open-market purchases and 13 sales totaling $5,869,340. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Harold BernsteinPresident, R&D & CMOSale16,141$26.93$434,743
Oct 1, 2026Jason V ColomaChief Executive OfficerSale34,501$27.02$932,258
Sep 29, 2026Atul DandekarCSBOSale7,500$27.06$202,921
Sep 4, 2026Harold BernsteinPresident, R&D & CMOSale9,705$26.22$254,502
Sep 3, 2026Harold BernsteinPresident, R&D & CMOSale10,295$26.24$270,111
Sep 3, 2026Atul DandekarCSBOSale6,434$26.24$168,811
Sep 3, 2026Phillips CourtneyGC and Corp. SecretarySale3,993$26.24$104,766
Sep 3, 2026Jason V ColomaChief Executive OfficerSale22,638$26.24$593,955
Sep 1, 2026Harold BernsteinPresident, R&D & CMOSale16,141$26.36$425,512
Sep 1, 2026Jason V ColomaChief Executive OfficerSale34,501$26.29$907,000

Common questions

MAZE insider trading FAQ

Are MAZE insiders buying or selling?
Over the last 90 days, MAZE insiders were net sellers, reporting $0.00 of open-market purchases and $5,869,340 of sales.
When was the last MAZE insider purchase?
No open-market insider purchase of Maze Therapeutics, Inc. stock was reported in the last 90 days.
Where does MAZE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Maze Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.